Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Smokey1958on Nov 08, 2021 10:25am
290 Views
Post# 34099494

RE:RE:RE:Before the End of the Month???

RE:RE:RE:Before the End of the Month???Good question, Midas. I can only speculate that in making this request that the FDA has and will do the following:

1. They have already reviewed the outcomes of the Brazil testing ...positively.
2. Whatever additional info was asked for in September has, again, already been reviewed.
3. They already have an expectation for the current testing, based on this most recent request.

As a consequence the outcomes of this testing will either meet or fail to meet these expectations. It won't take long at all for these to be assessed when you already know the expectation. Presuming that at this stage THRM management and partners have jumped through all the hoops, rendering a judgement on approval should take no time at all.

Cheers and GLTY!!!

1518midas wrote: The FDA would take some time to process the new informatiom and make their decision?


<< Previous
Bullboard Posts
Next >>